Iontophoretic delivery of 5-fluorouracil through excised human stratum corneum

被引:0
|
作者
Singh, Brahma N. [1 ]
Jayaswal, Shyam B. [1 ]
机构
[1] Banaras Hindu Univ, Inst Technol, Dept Pharmaceut, Varanasi 221005, Uttar Pradesh, India
来源
DRUG DISCOVERIES AND THERAPEUTICS | 2008年 / 2卷 / 02期
关键词
5-FU; Cathodal iontophoresis; Penetration enhancers; Transdermal; Current density;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The objective of this study was to determine the effects of ionization, current density and penetration enhancers on the iontophoretic delivery of 5-fluorouracil (5-FU) through excised human stratum corneum (HSC). The iontophoretic (cathodal) transport of 5-FU was assessed in vitro at three physiologically relevant pH values of 5.0, 7.4 and 8.0, at various levels of current density ranging between 0.15 to 0.98 mA/cm(2), and in the presence of suitable penetration enhancers, namely Azone (R) (AZ), lauryl alcohol (LA), and isopropyl myristate (IPM). The steady-state flux at constant current density (0.47 mA/cm(2)) was increased by approximately 19, 10 and 27 fold at pH 5, 7.4 and 8.0, respectively. The effect of current density at pH 7.4 exhibited a linear correlation between current density and steady-state flux (r = 0.98, p = 0.002), which indicates the potential of iontophoresis for controlled transdermal delivery of 5-FU. The combination of cathodal iontophoresis with IPM produced an additive enhancement which may be attributed to aggravated skin perturbation effect and increased skin conductivity. Other enhancers such as AZ and LA produced negative or no further enhancement respectively, when used in conjunction with cathodal iontophoresis. It may be therefore concluded that pH and current density play critical role during iontophoretic delivery of 5-FU, and combination of a chemical penetration enhancer and iontophoresis can not be always viewed as a synergistic strategy which should be evaluated on a case-by-case basis for each drug candidate/enhancer combination.
引用
收藏
页码:128 / 135
页数:8
相关论文
共 50 条
  • [41] Compression coated systems for colonic delivery of 5-fluorouracil
    Sinha, V. R.
    Singh, Asmita
    Singh, Sanjay
    Bhinge, J. R.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 (03) : 359 - 365
  • [42] In Vitro Cutaneous Application of ISCOMs on Human Skin Enhances Delivery of Hydrophobic Model Compounds Through the Stratum Corneum
    Henriette Baun Madsen
    Peter Ifversen
    Flemming Madsen
    Birger Brodin
    Ingrid Hausser
    Hanne Mørck Nielsen
    The AAPS Journal, 2009, 11 : 728 - 739
  • [43] Poly(butylcyanoacrylate) nanoparticles for topical delivery of 5-fluorouracil
    Simeonova, M
    Velichkova, R
    Ivanova, G
    Enchev, V
    Abrahams, I
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2003, 263 (1-2) : 133 - 140
  • [44] MEASURING THE UPTAKE OF AZONE INTO EXCISED HUMAN STRATUM-CORNEUM FROM THIN POLYMER-FILMS
    SCHUCKLER, F
    LEE, G
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) : 162 - 165
  • [45] Sponge delivery variables and tissue levels of 5-fluorouracil
    Wilkins, MR
    Occleston, NL
    Kotecha, A
    Waters, L
    Khaw, PT
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2000, 84 (01) : 92 - 97
  • [46] In Vitro Cutaneous Application of ISCOMs on Human Skin Enhances Delivery of Hydrophobic Model Compounds Through the Stratum Corneum
    Madsen, Henriette Baun
    Ifversen, Peter
    Madsen, Flemming
    Brodin, Birger
    Hausser, Ingrid
    Nielsen, Hanne Morck
    AAPS JOURNAL, 2009, 11 (04): : 728 - 739
  • [47] IONTOPHORETIC DELIVERY OF PROPRANOLOL HYDROCHLORIDE THROUGH HUMAN EPIDERMIS
    SINGH, S
    JAYASWAL, SB
    UPADHYAY, SN
    SINGH, J
    JOURNAL OF CONTROLLED RELEASE, 1992, 18 (02) : 165 - 170
  • [48] ORALLY-ADMINISTERED KETOCONAZOLE - ROUTE OF DELIVERY TO THE HUMAN STRATUM-CORNEUM
    HARRIS, R
    JONES, HE
    ARTIS, WM
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (06) : 876 - 882
  • [49] Colonic drug delivery of 5-fluorouracil: an in vitro evaluation
    Sinha, VR
    Mittal, BR
    Bhutani, KK
    Kumria, R
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 269 (01) : 101 - 108
  • [50] TRANSDERMAL DELIVERY OF 5-FLUOROURACIL AND ITS ALKYLCARBAMOYL DERIVATIVES
    SASAKI, H
    TAKAHASHI, T
    MORI, Y
    NAKAMURA, J
    SHIBASAKI, J
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 60 (01) : 1 - 9